Bioxytran, Inc
BIXT· OTC
Filed Nov 21, 2012 · 10-Q · 52 days after period end · 0001213900-12-006412
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | -$9.93K | $13.20K | $1.79K |
| Net Income | -$487.33K | -$346.04K | -$71.39K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 21, 2012 · 52 d after period end